ADAMTS13 and platelet-type von Willebrand disease: Additionally, it is valuable to monitor this enzyme activity during von Willebrand Disease (VWD) type 2A since point mutations in the VWF A2-domain during this disease enhance VWF susceptibility to ADAMTS13-mediated proteolysis.